TY - JOUR
T1 - Tofacitinib for rheumatoid arthritis
AU - Lopez-Olivo, Maria Angeles
AU - Bavineni, Mahesh
AU - Suarez-Almazor, Maria E.
PY - 2013/4/30
Y1 - 2013/4/30
N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the benefits and harms of tofacitinib for the treatment of rheumatoid arthritis. Our PICO question is as follows: Population: Adult patients with rheumatoid arthritis. Intervention: Tofacitinib alone or combined with any DMARD. Comparison: Placebo or DMARD. Outcomes: Efficacy, radiographic, patient-reported and safety outcomes.
AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the benefits and harms of tofacitinib for the treatment of rheumatoid arthritis. Our PICO question is as follows: Population: Adult patients with rheumatoid arthritis. Intervention: Tofacitinib alone or combined with any DMARD. Comparison: Placebo or DMARD. Outcomes: Efficacy, radiographic, patient-reported and safety outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85000647372&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85000647372&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD010476
DO - 10.1002/14651858.CD010476
M3 - Article
AN - SCOPUS:85000647372
SN - 1361-6137
VL - 2013
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 4
M1 - CD010476
ER -